A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol

Peer Review reports

Original Submission
28 Oct 2014	Submitted	Original manuscript
8 Dec 2014	Author responded	Author comments - Corran Roberts
Resubmission - Version 2
8 Dec 2014	Submitted	Manuscript version 2
Publishing
11 Dec 2014	Editorially accepted
19 Dec 2014	Article published	10.1186/1471-2407-14-983

Back to article page